International Conference on Malignancies in HIV/AIDS (ICMH)

The International Conference on Malignancies in HIV/AIDS (ICMH), formerly known as the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI), is a conference presented by the Office of HIV and AIDS Malignancy.

This conference, which takes place once every one to two years, is the only forum that is solely focused on presentation of basic, epidemiologic, and clinical aspects of research on malignancies in HIV-infected and other immunosuppressed individuals. The ICMH is designed to facilitate the exchange of information between laboratory and clinical investigators to accelerate the translation of basic scientific discoveries into clinical applications.

The ICMH agenda focuses on advances in clinical investigation of malignant diseases associated with HIV and other acquired immunodeficiency states, including developments in:

Viral oncology
Immunology
Genetics
Epidemiology
Pathogenesis
Drug discovery
Early diagnosis

Past presentations and lectures have focused on the latest research and findings in human papillomavirus (HPV), Epstein-Barr virus (EBV), and Kaposi’s sarcoma-associated herpes virus/human herpes virus 8 (KSHV/HHV-8), as well as their related malignancies – lymphomas, ano-genital carcinomas, Kaposi's sarcoma, and Hodgkin's disease.

Who Should Attend

ICMH is organized to provide informational and networking resources for:

Clinical and laboratory investigators
Post-docs
Students
Physicians
Health care workers
Anyone involved, interested, or participating in malignancy research in HIV/AIDS and other immunodeficiencies

Programs, Abstracts, and Proceedings from Recent Meetings

Programs and abstract books from meetings prior to 2010 are archived for reference purposes. View and download archived meeting materials here.

The proceedings of the 1997, 1998, and 1999 conferences were published in the following journals: